🟢 Corcept Therapeutics is trading 4.12% up today as risk-on sentiment strengthens

Corcept Therapeutics is trading at $114.83 (+4.12%) on September 21, 2026, amid a stronger risk-on market.

• The S&P 500 is up 1.00% and Nasdaq is up 1.50%.
• No new company-specific catalyst was identified during morning trading; the September 18 CHMP recommendation for relacorilant was favorable but preceded today’s move.
• Falling oil prices, lower Treasury yields, and improving sentiment are supporting equities broadly. [Event ID: 6ab139b3b8b60cd6f415f119]